Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures

Paediatric Anaesthesia

Volumn 21, Issue 6, 2011, Pages 653-662

  Brunette, Katharine E J ^a   Anderson, Brian J ^a,b   Thomas, Jennifer ^c   Wiesner, Lubbe ^d   Herd, David W ^e   Schulein, Simone ^c  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e MATER CHILDREN S HOSPITAL   (Australia)

Author keywords

burns; children; ketamine; oral dosing; procedural sedation

Indexed keywords

CEFAZOLIN; GLYCOPYRRONIUM BROMIDE; KETAMINE; MIDAZOLAM; MORPHINE; PARACETAMOL;

ARTICLE; BODY SURFACE; BOLUS INJECTION; BURN; CHILD; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADMINISTRATION, ORAL; ANESTHETICS, DISSOCIATIVE; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; BURNS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALF-LIFE; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; KETAMINE; MALE; PAIN;

EID: 79955466418     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2011.03548.x     Document Type: Article

References (43)

1. Herd D, Anderson BJ,. Ketamine disposition in children presenting for procedural sedation and analgesia in a children's emergency department. Pediatr Anesth 2007; 17: 622-629. (Pubitemid 46911065)
2. Green SM, Krauss B,. Ketamine is a safe, effective, and appropriate technique for emergency department paediatric procedural sedation. Emerg Med J 2004; 21: 271-272. (Pubitemid 38585096)
3. Green SM, Roback MG, Krauss B,. Anticholinergics and ketamine sedation in children: a secondary analysis of atropine versus glycopyrrolate. Acad Emerg Med 2010; 17: 157-162.
4. Green SM, Roback MG, Krauss B, et al. Predictors of emesis and recovery agitation with emergency department ketamine sedation: an individual-patient data meta-analysis of 8,282 children. Ann Emerg Med 2009; 54: 171-180.
5. Green SM, Roback MG, Krauss B, et al. Predictors of airway and respiratory adverse events with ketamine sedation in the emergency department: an individual-patient data meta-analysis of 8,282 children. Ann Emerg Med 2009; 54: 158-168.
6. Heinz P, Geelhoed GC, Wee C, et al. Is atropine needed with ketamine sedation? A prospective, randomised, double blind study. Emerg Med J 2006; 23: 206-209. (Pubitemid 44295348)
7. Shah S, Shah S, Apuya J, et al. Combination of oral ketamine and midazolam as a premedication for a severely autistic and combative patient. J Anesth 2009; 23: 126-128.
8. Darlong V, Shende D, Subramanyam MS, et al. Oral ketamine or midazolam or low dose combination for premedication in children. Anaesth Intensive Care 2004; 32: 246-249. (Pubitemid 38425607)
9. Warner DL, Cabaret J, Velling D,. Ketamine plus midazolam, a most effective paediatric oral premedicant. Paediatr Anaesth 1995; 5: 293-295.
10. Herd D, Anderson B,. Lack of pharmacokinetic information in children leads clinicians to use experience and trial-and-error to determine how best to administer ketamine. Ann Emerg Med 2007; 49: 824.
11. Roback MG, Wathen JE, MacKenzie T, et al. A randomized, controlled trial of i.v. versus i.m. ketamine for sedation of pediatric patients receiving emergency department orthopedic procedures. Ann Emerg Med 2006; 48: 605-612. (Pubitemid 44556892)
12. Green SM, Krauss B,. Should I give ketamine i.v. or i.m.? Ann Emerg Med 2006; 48: 613-614. (Pubitemid 44556893)
13. Herd DW, Anderson BJ, Holford NH,. Modeling the norketamine metabolite in children and the implications for analgesia. Pediatr Anesth 2007; 17: 831-840. (Pubitemid 47221150)
14. Wieber J, Gugler R, Hengstmann JH, et al. Pharmacokinetics of ketamine in man. Anaesthesist 1975; 24: 260-263.
15. Domino EF, Domino SE, Smith RE, et al. Ketamine kinetics in unmedicated and diazepam-premedicated subjects. Clin Pharmacol Ther 1984; 36: 645-653. (Pubitemid 15224670)
16. Domino EF, Zsigmond EK, Domino LE, et al. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth Analg 1982; 61: 87-92. (Pubitemid 12184628)
17. Clements JA, Nimmo WS,. Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 1981; 53: 27-30. (Pubitemid 11210925)
18. Grant IS, Nimmo WS, McNicol LR, et al. Ketamine disposition in children and adults. Br J Anaesth 1983; 55: 1107-1111. (Pubitemid 14244442)
19. Grant IS, Nimmo WS, Clements JA,. Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth 1981; 53: 805-810. (Pubitemid 11044337)
20. Beal SL, Sheiner LB, Boeckmann A,. Nonmem User's Guide. San Francisco: Division of Pharmacology, University of California, 1999.
21. Efron B, Tibshirani R,. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1986; 1: 54-77.
22. Post TM, Freijer JI, Ploeger BA, et al. Extensions to the visual predictive check to facilitate model performance evaluation. J Pharmacokinet Pharmacodyn 2008; 35: 185-202.
23. Tod M, Jullien V, Pons G,. Facilitation of drug evaluation in children by population methods and modelling. Clin Pharmacokinet 2008; 47: 231-243. (Pubitemid 351367434)
24. Brendel K, Dartois C, Comets E, et al. Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004. Clin Pharmacokinet 2007; 46: 221-234. (Pubitemid 46425648)
25. Bergstrand M, Hooker AC, Wallin JE, et al. Prediction corrected visual predictive checks. ACOP: American College on Pharmacometrics, 2009: Available at:. Accessed 6 January, 2011.
26. Yanagihara Y, Ohtani M, Kariya S, et al. Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers. Biopharm Drug Dispos 2003; 24: 37-43. (Pubitemid 36124167)
27. Chong C, Schug SA, Page-Sharp M, et al. Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: preliminary findings from a three-way randomized, crossover study. Clin Drug Investig 2009; 29: 317-324.
28. Nguyen NQ, Ng MP, Chapman M, et al. The impact of admission diagnosis on gastric emptying in critically ill patients. Crit Care 2007; 11: R16.
29. Sallam HS, Oliveira HM, Liu S, et al. Mechanisms of burn-induced impairment in gastric slow waves and emptying in rats. Am J Physiol Regul Integr Comp Physiol 2010; 299: R298-R305.
30. Wright PM, Fisher DM,. Can bioavailability of low-variance drugs be estimated with an unpaired, sparse sampling design? Clin Pharmacol Ther 1998; 63: 437-443. (Pubitemid 28214967)
31. Ahsman MJ, Hanekamp M, Wildschut ED, et al. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet 2010; 49: 407-419.
32. Anderson BJ, Holford NHG,. Tips and traps analysing paediatric PK data. Pediatr Anesth 2011; 21: 222-237.
33. Hijazi Y, Boulieu R,. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 2002; 30: 853-858. (Pubitemid 34671099)
34. Sigtermans M, Dahan A, Mooren R, et al. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic- pharmacodynamic modeling study in healthy volunteers. Anesthesiology 2009; 111: 892-903.
35. Herd DW, Anderson BJ, Keene NA, et al. Investigating the pharmacodynamics of ketamine in children. Pediatr Anesth 2008; 18: 36-42. (Pubitemid 350264604)
36. Hartvig P, Larsson E, Joachimsson PO,. Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine. J Cardiothorac Vasc Anesth 1993; 7: 148-153. (Pubitemid 23111801)
37. Ebert B, Mikkelsen S, Thorkildsen C, et al. Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. Eur J Pharmacol 1997; 333: 99-104. (Pubitemid 27380456)
38. Shimoyama M, Shimoyama N, Gorman AL, et al. Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine. Pain 1999; 81: 85-93. (Pubitemid 29199904)
39. Holtman JR Jr, Crooks PA, Johnson-Hardy JK, et al. Effects of norketamine enantiomers in rodent models of persistent pain. Pharmacol Biochem Behav 2008; 90: 676-685.
40. Karlsson M, Jonsson E, Wiltse C, et al. Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients. J Pharmacokinet Biopharm 1998; 26: 207-246. (Pubitemid 28496599)
41. Anderson BJ, Meakin GH,. Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr Anaesth 2002; 12: 205-219. (Pubitemid 34264439)
42. Anderson BJ, Holford NH,. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48: 303-332. (Pubitemid 351738156)
43. Anderson BJ, Holford NH,. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet 2009; 24: 25-36.